Authors:
LEBRET T
GAUDEZ F
HERVE JM
BARRE P
LUGAGNE PM
BOTTO H
Citation: T. Lebret et al., LOW-DOSE BCG INSTILLATIONS IN THE TREATMENT OF STAGE T1 GRADE 3 BLADDER-TUMORS - RECURRENCE, PROGRESSION AND SUCCESS, European urology, 34(1), 1998, pp. 67-72
Authors:
LEBRET T
HERVE JM
BARRE P
GAUDEZ F
LUGAGNE PM
BARBAGELATTA M
BOTTO H
Citation: T. Lebret et al., URETHRAL RECURRENCE OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - PREDICTIVE VALUE OF PREOPERATIVE LATERO-MONTANAL BIOPSIES AND URETHRAL FROZEN-SECTIONS DURING PROSTATOCYSTECTOMY, European urology, 33(2), 1998, pp. 170-174
Authors:
LEBRET T
BECETTE V
BARBAGELATTA M
HERVE JM
GAUDEZ F
BARRE P
LUGAGNE PM
BOTTO H
Citation: T. Lebret et al., CORRELATION BETWEEN P53 OVER-EXPRESSION AND RESPONSE TO BACILLUS-CALMETTE-GUERIN THERAPY IN A HIGH-RISK SELECT POPULATION OF PATIENTS WITH T1G3 BLADDER-CANCER, The Journal of urology, 159(3), 1998, pp. 788-791
Authors:
LUGAGNE PM
HERVE JM
LEBRET T
BARRE P
MOLLIER S
BOTTO H
Citation: Pm. Lugagne et al., URETEROILEAL IMPLANTATION IN ORTHOTOPIC NEOBLADDER WITH THE LE-DUC-CAMEY MUCOSAL-THROUGH TECHNIQUE - RISK OF STENOSIS AND LONG-TERM FOLLOW-UP, The Journal of urology, 158(3), 1997, pp. 765-767
Authors:
SALOMON L
LUGAGNE PM
HERVE JM
BARRE P
LEBRET T
BOTTO H
Citation: L. Salomon et al., NO EVIDENCE OF METABOLIC DISORDERS 10 TO 22 YEARS AFTER CAMEY TYPE-I ILEAL ENTEROCYSTOPLASTY, The Journal of urology, 157(6), 1997, pp. 2104-2106